No single company dominates this field: the top-ranked assignee holds 216 records, but the top 5 assignees combined account for only 4.6% of the 17,095 records in scope, and the top 10 reach just 7.8%. This is a fragmented landscape with a long tail of companies and universities each holding a small number of filings. A freedom-to-operate review therefore needs to look well beyond the largest few filers to be reliable.

Filings peaked at 1,035 records in 2019 and, using complete-year data, fell from 980 in 2021 to 696 in 2024 — a confirmed -29% decline. Figures for 2025 and 2026 appear lower still, but that reflects normal publication lag of roughly 18 months rather than an actual continued drop. The honest read is a real cooling from the 2019 high, with the most recent trajectory not yet fully visible.

The dataset's IPC composition shows A61K (medicinal preparations) at 28.1% of the 17,095 records and G01N (material analysis and testing) at 17.1%, followed by C07D (heterocyclic compounds) at 14.8%. This confirms that most patent activity referencing FTIR techniques like attenuated total reflectance and spectral libraries sits in pharmaceutical and material-testing applications, not in spectrometer hardware design itself. Because records can carry multiple IPC codes, these shares overlap rather than sum to 100%.

Given the fragmented ownership and the concentration of filings in a handful of IPC subclasses, thinner claim density appears in narrower operational areas such as water vapour compensation methods, purge-gas-free interferometer sealing, and automated spectral library matching for mixed analytes. These sit adjacent to the dense classes rather than inside them, which is typically where a narrowly drafted first claim has room to stand. Confirming this requires a targeted prior-art search on the specific sub-area rather than relying on the aggregate IPC shares alone.

That filing, assigned to Sony Corporation, claims an attenuated total reflectance FTIR method for evaluating lubricant amount on a magnetic recording layer, specifically tying a defined absorption-area difference in the 2940-2800 cm-1 band (0.01 to 0.30) to the measurement outcome. It blocks that specific measurement protocol and numeric range for magnetic media lubricant evaluation, not ATR-FTIR measurement generally. Anyone measuring a different analyte, a different wavenumber band, or a different area-difference range would likely sit outside its claim scope, though a full claim chart is the only way to confirm that for a specific product.

The United States leads with 5,500 records, followed by the European Patent Office at 2,590 and the WIPO/PCT route at 2,476. Australia, Canada and India each fall in the 800-900 record range. This pattern suggests most applicants build a US-anchored filing strategy and extend selectively into a small number of major jurisdictions, rather than filing broadly and simultaneously worldwide.